CrushSCI.com
Journal Selection & Manuscript Polishing Services
Gastric Cancer journal cover Medicine
Back to journal directory

Review Cycle Records

Gastric Cancer

Springer SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q1
98.1Average days
96Median days
3Fastest days
171Longest days
1182025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

90 days

Baseline IL-6 independently predicts severe immune-related toxicity and poor survival in advanced gastric cancer treated with immunotherapy

AuthorsWanrong Liu; Hui Tang; Ningning Li; Wei Qiu; Xiaoyuan Li; Lin Zhao

Affiliations1. Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; 2. Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China; 3. Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Source PDF DOI Publisher page
98 days

Modified transferrin saturation is associated with postoperative complications in patients undergoing curative gastrectomy for gastric cancer

AuthorsChishou Mitsuura; Satoshi Ida; Hiroki Tsubakihara; Kohei Yamashita; Kojiro Eto; Chihiro Matsumoto; Keisuke Kosumi; Kazuto Harada; Yuji Miyamoto; Masaaki Iwatsuki

Affiliations1. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Source PDF DOI Publisher page
53 days

Nodal burden modifies the prognostic significance of perineural invasion in stage I–III gastric cancer

AuthorsQi Wang; Hongxue Meng; Shizheng Xiong; Xiaoyan Zhang; Midie Xu

Affiliations1. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3. Institute of Pathology, Fudan University, Shanghai, China; 4. Department of Pathology, Harbin Medical University Cancer Hospital, Heilongjiang, China

Source PDF DOI Publisher page
72 days

Therapeutic management of resectable mismatch-repair deficient/microsatellite instability-high gastroesophageal adenocarcinoma: a real-world analysis from Austria

AuthorsMartin Korpan; Daniel Nothdurfter; Bernhard Doleschal; Lukas Weiss; Sophie Roider-Schur; Leopold Öhler; Ewald Wöll; Julia M. Berger; Elisabeth S. Bergen; Gerald W. Prager; Behrang Mozayani; Anna S. Berghoff; Matthias Preusser; Hannah C. Puhr; Florian Huemer; Aysegül Ilhan-Mutlu

Affiliations1. Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; 2. Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria; 3. Department of Internal Medicine I for Hematology With Stem Cell Transplantation, Hemostaseology, and Medical Oncology, Ordensklinikum Linz, Linz, Austria; 4. Department of Internal Medicine III With Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; 5. Department of Medicine I, Oncology, St. Josef Krankenhaus, Vienna, Austria; 6. Department of Internal Medicine, St. Vinzenz Hospital Zams, Zams, Austria; 7. Department of Pathology, Medical University of Vienna, Vienna, Austria

Source PDF DOI Publisher page
112 days

Multimodal features and prognostic risk assessment in locally advanced gastric cancer patients following neoadjuvant therapy based on machine learning algorithms: a multicenter study

AuthorsLi Liu; Qing Zhong; Caiming Weng; Lihong Chen; Yuqin Sun; Shichao Wu; Minxian Zhuang; Wen Li; Guojun Xia; Zhixin Shangguan; Dong Wu; Chaohui Zheng; Jianwei Xie; Qiyue Chen; Lisheng Cai; Changming Huang; Ping Li

Affiliations1. Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China; 2. Department of Radiology, Fujian Medical University Union Hospital, Fuzhou, China; 3. Department of Gastrointestinal Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China; 4. Department of Gastrointestinal Surgery, The First Hospital of Putian City, Putian, China; 5. Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, China; 6. Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, China; 7. Department of Gastrointestinal Surgery, Shaoxing Central Hospital, Shaoxing, China

Source PDF DOI Publisher page
96 days

Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects

AuthorsKomei Kuge; Junko Mukohyama; Yoshimi Yasukawa; Yuko Ishibashi; Hiroki Masuda; Tomohiko Yasuda; Yasukazu Ohmoto; Hideyuki Takeshima; Akihisa Matsuda; Hiroshi Yoshida; Yasuyuki Seto; James R. Goldenring; Toshikazu Ushijima; Sachiyo Nomura

Affiliations1. Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 2. Department of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan; 3. Division of Frontier Surgery, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 4. Division of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan; 5. Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 6. Department of Pharmacokinetics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, The University of Tokushima, Tokushima, Japan; 7. Section of Surgical Sciences, Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, USA; 8. Department of Cell and Developmental Biology, Vanderbilt University, Nashville, USA; 9. Nashville Veterans Affairs Medical Center, Nashville, USA; 10. Department of Clinical Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Shinagawa-Ku, Tokyo, Japan; 11. Isotope Science Center, The University of Tokyo, Tokyo, Japan

Source PDF DOI Publisher page
143 days

Comparison of minimally invasive surgery and open surgery following chemotherapy for cStage IVb gastric cancer: a multicenter retrospective cohort study

AuthorsYusuke Fujii; Shigeo Hisamori; Nobuaki Hoshino; Seiichiro Kanaya; Eiji Tanaka; Yoshito Yamashita; Akira Miki; Kosuke Toda; Michihiro Yamamoto; Yosuke Kinjo; Dai Manaka; Hiroaki Hata; Hironori Kawada; Shotaro Matsuda; Atsushi Itami; Kyoichi Hashimoto; Kenjiro Hirai; Sanae Nakajima; Hiroshi Okabe; Masazumi Sakaguchi; Yuichiro Kawamura; Takashi Sakamoto; Shintaro Okumura; Tatsuto Nishigori; Shigeru Tsunoda; Kazutaka Obama

Affiliations1. Department of Surgery, Kyoto University Hospital, Kyoto, Japan; 2. Kyoto Esophageal and Gastric Surgery Group, Kyoto, Japan; 3. Department of Gastroenterological Surgery, Japanese Red Cross Osaka Hospital, Osaka, Japan; 4. Department of Gastroenterological Surgery, Kitano Hospital, Osaka, Japan; 5. Department of Gastroenterological Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan; 6. Department of Gastroenterological Surgery, Toyooka Hospital, Toyooka, Japan; 7. Department of Surgery, Shiga General Hospital, Moriyama, Japan; 8. Department of Gastroenterological Surgery, Tenri Hospital, Tenri, Japan; 9. Department of Gastroenterological Surgery and Oncology, Himeji Medical Center, Himeji, Japan; 10. Department of Surgery, Gastrointestinal Center, Kyoto Katsura Hospital, Kyoto, Japan; 11. Department of Surgery, National Hospital Organization, Kyoto Medical Center, Kyoto, Japan; 12. Department of Gastroenterological Surgery, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan; 13. Department of Surgery and Transplant Surgery, Kobe City Medical Center General Hospital, Kobe, Japan; 14. Department of Surgery, Kobe City Nishi-Kobe Medical Center, Kobe, Japan; 15. Department of Gastroenterological Surgery, Uji-Tokushukai Medical Center, Uji, Japan; 16. Department of Surgery, Japanese Red Cross Otsu Hospital, Otsu, Japan; 17. Department of Gastroenterological Surgery, Kobe City Medical Center West Hospital, Kobe, Japan; 18. Department of Gastroenterological Surgery, New Tokyo Hospital, Matsudo, Japan; 19. Department of general Surgery, Kyoto City Hospital, Kyoto, Japan; 20. Department of Surgery, Kokura Memorial Hospital, Kitakyushu, Japan

Source PDF DOI Publisher page
171 days

Loss of EMILIN-1/integrin axis drives microenvironmental reprogramming in gastric tumorigenesis

AuthorsAlessandra Capuano; Maddalena Vescovo; Samanta Muzzin; Enrica Timis; Laura Cesaratto; Eliana Pivetta; Roberto Doliana; Antonio Palumbo; Renato Cannizzaro; Vincenzo Canzonieri; Eugenio Scanziani; Simone Canesi; Gustavo Baldassarre; Maurizio Mongiat; Paola Spessotto

Affiliations1. Molecular Oncology Unit, Centro Di Riferimento Oncologico Aviano, (CRO) IRCCS, Aviano, Italy; 2. Dipartimento Di Medicina, Università Degli Studi Di Udine, Udine, Italy; 3. Pathology Unit, Centro Di Riferimento Oncologico Aviano, (CRO) IRCCS, Aviano, Italy; 4. Oncological Gastroenterology Unit, Centro Di Riferimento Oncologico Aviano, (CRO) IRCCS, Aviano, Italy; 5. Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; 6. Dipartimento Di Medicina Veterinaria E Scienze Animali (DIVAS), Università Degli Studi Di Milano, Milan, Italy; 7. Mouse & Animal Pathology Lab (MAPLab), Milan, Italy

Source PDF DOI Publisher page
163 days

Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025)

AuthorsHidekazu Hirano; Yoichi Naito; Tsuyoshi Takahashi; Seiichi Hirota; Kyoung-Mee Kim; Min-Hee Ryu; Jian Wang; Hui Cao; Jian Li; Chien-Feng Li; Chueh-Chuan Yen; Han-Kwang Yang; Hwoon-Yong Jung; Chun-Nan Yeh; Hsiu-Po Wang; Li-Tzong Chen; Lin Shen; Yoon-Koo Kang; Toshirou Nishida

Affiliations1. Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; 2. Department of General Internal Medicine/Experimental Therapeutics/Medical Oncology, National Cancer Center Hospital East, Chiba, Japan; 3. Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan; 4. Department of Diagnostic Pathology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan; 5. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 6. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 7. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; 8. Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 9. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Cell & Gene Therapy for Solid Tumor, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China; 10. National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; 11. Division of Clinical Research, Department of Medical Research, and Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; 12. School of Medicine, College of Medicine, and Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan; 13. Department of Surgery, Seoul National University Hospital, Seoul, Republic of Korea; 14. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 15. Department of Surgery, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taipei, Taiwan; 16. Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; 17. Department of Internal Medicine, Kaohsiung Medical University Hospital, and College of Medicine and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; 18. Department of Oncology, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si, Republic of Korea; 19. Department of Surgery, Japan Community Healthcare Organization Osaka Hospital, Fukushima-ku, Osaka, Japan; 20. Rare Cancer Center, National Cancer Center, Tokyo, Japan

Source PDF DOI Publisher page
129 days

Germline whole-exome sequencing identifies CTNND1 as a candidate gene for hereditary gastric cancer in a large Brazilian cohort

AuthorsDeivid Calebe de Souza; Thaliane Buranello; Dario Tenorio Tavares Neto; Janina Pontes Pisani; Giovanna Napolitano Pereira Ribeiro; Marcia Olandoski; David Schlesinger; João Paulo Kitajima; Danilo Vilela Viana; Maria Isabel Achatz

Affiliations1. Hospital Sírio-Libanês, São Paulo, Brazil; 2. Oncoclínicas Ribeirão Preto, Ribeirão Preto, Brazil; 3. Centro Universitário da Fundação Assis Gurgacz, Cascavel, Brazil; 4. Universidade Federal de São Paulo, São Paulo, Brazil; 5. Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; 6. Mendelics, São Paulo, Brazil

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.